Effective June 1st: Changes Regarding 'CureApp HT Hypertension Treatment Support App' Following the FY2026 Medical Fee Revision – PR TIMES

News Highlights

With the FY2026 medical fee revision, changes concerning the "CureApp HT Hypertension Management App" will take effect from June 1st. This revision suggests an expansion of insurance coverage for digital health devices and increased evaluation for treatments utilizing them. From an M&A and business succession perspective, mid-to-long-term strategies considering the medical fee revision cycle, economies of scale through group participation, and the utilization of tax schemes including conversion to specific medical corporations or social medical corporations can be key discussion points.

M&A Medical Editorial Department's Perspective

令和8年度診療報酬改定でCureApp HTのような高血圧治療補助アプリが対象となることは、デジタルヘルスの保険適用がますます進む兆しです。これは、単なる医療機器の導入に留まらず、遠隔診療やデータ活用といった新たな診療スタイルへの移行を意味します。医療機関経営者としては、こうしたテクノロジー投資を単独で行うか、あるいはM&Aを通じてグループ化し、設備投資負担や人材育成コストを分散させるか、といった戦略的判断がより重要になります。特に、地域医療連携のハブとなるような病院や、IT投資に積極的なクリニックが、この変化を成長機会と捉え、事業承継やM&Aの検討を進める可能性は高いでしょう。単に「アプリを導入する」のではなく、将来の診療報酬改定を見据え、事業ポートフォリオにどう組み込むか、という視点が不可欠です。

Points Raised by This News

• The expansion of insurance coverage for digital health directly impacts the IT investment strategies of medical institutions.
• Introducing apps like CureApp HT requires management strategies based on remote care and data utilization.
• Economies of scale through group affiliation can be an effective option for dispersing the burden of high IT investment costs.
• It is time to consider incorporating digital tools into the business portfolio, looking ahead to future medical fee revisions.

Practical Questions Arising from This News

• What are the specific benefits in terms of medical fees from introducing digital health devices like CureApp HT?
• Considering our institution's size and regional characteristics, how effective is group affiliation through M&A in reducing IT investment burdens?
• How is the transition to specific medical corporation or social medical corporation status linked to investments in digital health?

If You Feel "Should I Consult Too?"

The trend of evaluating digital health devices like CureApp HT in medical fee revisions is a signal for medical institutions to consider IT investment and business strategy as an integrated whole. If investing independently is difficult, or if you wish to strengthen your IT infrastructure with future business succession in mind, you should explore possibilities for group affiliation through M&A or business restructuring utilizing tax schemes. This is a good opportunity to discuss concrete options for maintaining and strengthening your institution's competitiveness in light of the latest medical fee revision trends, in collaboration with experts.

M&A Medical (CentralMedience Inc.) is a business succession support service for medical corporations, hospitals, and clinics, certified by the Small and Medium Enterprise Agency as an M&A support institution. We provide comprehensive support.Success FeeWe handle consultations with strict confidentiality.Contact Us for a Free Consultation